Identification of a TLR4- and TRIF-dependent Activation Program of Dendritic Cells
Overview
Authors
Affiliations
Dendritic cell activation by Toll-like receptors (TLR) is crucial for the generation of protective immune responses. In addition to the common myeloid differentiation factor 88 (MyD88)-dependent signaling pathway, TLR4 engages the adaptor protein Toll/IL-1 receptor (TIR)-domain-containing adaptor inducing IFN-beta (TRIF), leading to interferon regulatory factor 3 (IRF-3) activation and type I interferon production. Using microarray expression profiling we now identify TRIF as a major regulator of the TLR4-triggered activation program of dendritic cells. We show that the expression of 47% of the genes that are responsive to TLR4 stimulation in wild-type dendritic cells is significantly altered in cells carrying a loss-of-function mutation of TRIF. Specifically, expression of IL-12, IL-18, and IL-23 was impaired in the absence of functional TRIF, suggesting that TLR4-promoted Th1 responses are TRIF-dependent. Furthermore, we provide evidence that TRIF regulates TLR4-mediated gene expression both by type I IFN-dependent and -independent mechanisms. Whereas dendritic cell production of CXCL10 and CCL12 was dependent on both TRIF and the type I interferon receptor, expression of IL-6 required TRIF but not type I interferon activity. Functional TRIF was also required for the normal induction of numerous genes considered important for host defense against diverse pathogens.Together, these data therefore identify TRIF as a crucial regulator of TLR4-dependent dendritic cell responses.
Colaco M, Cruz M, de Almeida L, Borges O Pharmaceutics. 2024; 16(10).
PMID: 39458637 PMC: 11510408. DOI: 10.3390/pharmaceutics16101308.
Role of long non-coding RNA in inflammatory bowel disease.
Hu Y, Lu Y, Fang Y, Zhang Q, Zheng Z, Zheng X Front Immunol. 2024; 15:1406538.
PMID: 38895124 PMC: 11183289. DOI: 10.3389/fimmu.2024.1406538.
Transcriptional control of metabolism by interferon regulatory factors.
Ahmad Z, Kahloan W, Rosen E Nat Rev Endocrinol. 2024; 20(10):573-587.
PMID: 38769435 PMC: 11392651. DOI: 10.1038/s41574-024-00990-0.
Ai H, Li B, Meng F, Ai Y Front Immunol. 2022; 13:907646.
PMID: 35774781 PMC: 9238352. DOI: 10.3389/fimmu.2022.907646.
Chinthamani S, Settem R, Honma K, Stafford G, Sharma A Pathog Dis. 2022; 80(1).
PMID: 35404415 PMC: 9053306. DOI: 10.1093/femspd/ftac008.